| Patents for A61P 9 - Drugs for disorders of the cardiovascular system (159,484) |
|---|
| 01/08/2003 | EP1272183A1 Methods and compositions useful in enhancing oxygen delivery to cells |
| 01/08/2003 | EP1272180A1 Concentrated solutions of carvedilol |
| 01/08/2003 | EP1272179A1 Hydrophilic molecular disperse solutions of carvedilol |
| 01/08/2003 | EP1272178A2 Bilirubin or biliverdin degradation fragments |
| 01/08/2003 | EP1272177A1 Method and formulation for treating resistance to antihypertensives and related conditions |
| 01/08/2003 | EP1272175A2 Il-8 receptor antagonists |
| 01/08/2003 | EP1272172A2 Use of breakers of advanced glycation endproducts for treating deleterious effects of aging and debilitating diseases |
| 01/08/2003 | EP1272169A2 Use of 13-hode as a regulator of vascular biocompatibility and an inhibitor of cell hyperplasia |
| 01/08/2003 | EP1272167A1 Hydrophilic/lipophilic polymeric matrix dosage formulation |
| 01/08/2003 | EP1218407A4 Uses of kappa-conotoxin pviia |
| 01/08/2003 | EP1123276B1 N-(2-aryl-propionyl)-sulfonamides and pharmaceutical preparations containing them |
| 01/08/2003 | EP1119355B1 Naphthalenecarboxamides as tachykinin receptor antagonists |
| 01/08/2003 | EP1087973B1 Imidazotriazolopyrimidines used as a drug having an adenosine antagonist activity |
| 01/08/2003 | EP1066061A4 Use of scatter factor to enhance angiogenesis |
| 01/08/2003 | EP0983294B1 B-ring estratriene diol sulphates |
| 01/08/2003 | EP0934286B1 3-alkoxyisoxazol-4-yl-substituted 2-amino carboxylic acid compounds |
| 01/08/2003 | EP0915881B1 Pyrroloazepine compounds |
| 01/08/2003 | EP0859622B1 Extracts of shark cartilage |
| 01/08/2003 | EP0853480B1 Use of a thienotriazolodiazepine to increase apolipoprotein a-i levels |
| 01/08/2003 | EP0817646B1 Methods of treating inflammation and compositions therefor |
| 01/08/2003 | CN1390231A Metal-binding compounds and uses thereof |
| 01/08/2003 | CN1390228A Orally active A adenosine receptor agonists |
| 01/08/2003 | CN1390222A Imidazole compounds used as phosphodiesterase VII inhibitors |
| 01/08/2003 | CN1390220A Kinase inhibitors as therapeutic agents |
| 01/08/2003 | CN1390219A Pyrazolopyrimidines as therapeutic agents |
| 01/08/2003 | CN1390215A 酪氨酸激酶抑制剂 Tyrosine kinase inhibitor |
| 01/08/2003 | CN1390200A Inhibitors of metalloproteinases |
| 01/08/2003 | CN1390199A Prostaglandin derivatives |
| 01/08/2003 | CN1390196A Novel derivatives of dicarboxylic acid having pharmaceutical properties |
| 01/08/2003 | CN1390193A Novel dicarboxylic acid derivatives with pharmaceutical properties |
| 01/08/2003 | CN1390141A Nucleic acid-containing complex |
| 01/08/2003 | CN1390137A A Blocking monoclonal antibody to VLA-1 and its use for the treatment of inflammatory disorders |
| 01/08/2003 | CN1390128A Use of adatanserin for treating neurogenerative disorders |
| 01/08/2003 | CN1390122A Tissue factor antagonists and methods of use thereof |
| 01/08/2003 | CN1390118A Dextrose and insulin fluid formulation for intravenous infusion |
| 01/08/2003 | CN1389269A Compound of polypeptide-liposome and human vascular endothelial growth factor gene recombination plasmid and its use |
| 01/08/2003 | CN1389263A Compound ginkgo capsule |
| 01/08/2003 | CN1389241A Composite medicine for treating hircus, tinea and external piles |
| 01/08/2003 | CN1389240A Gingko leaf powder for injection and its prepn. |
| 01/08/2003 | CN1389232A Diles treating medicine and its prepn. |
| 01/08/2003 | CN1389226A Arborescent aloe granule |
| 01/08/2003 | CN1389215A Hongbing ointment as one kind of locally administrated prepn. |
| 01/08/2003 | CN1389211A Puerarin injection and its prepn. process |
| 01/08/2003 | CN1389209A Myocarditis treating medicine |
| 01/08/2003 | CN1389205A Soft bilobalide capsule and its prepn. |
| 01/08/2003 | CN1098263C Pyridin-2-yl-methylaminederivatives, method of preparing and application as medicine |
| 01/08/2003 | CN1098256C Substd. benzenesulfonamide derivatives as prodrugs of COX-2 inhibitors |
| 01/08/2003 | CN1098254C Sulfonamides |
| 01/08/2003 | CN1098100C Chinese medicine powder for treating hypertension and arteriosclerosis |
| 01/08/2003 | CN1098084C Marine active substance and composition comprising the same |
| 01/08/2003 | CN1098070C Guanylhydrazones for treating inflammatory conditions |
| 01/07/2003 | US6504057 Fluorophenyl-substituted alkenylcarboxylic acid guanidides, process for their preparation, their use as a medicament or diagnostic, and medicament containing them |
| 01/07/2003 | US6504005 Long-acting drugs and pharmaceutical compositions comprising them |
| 01/07/2003 | US6503930 Pyrazole derivatives as p38 kinase inhibitors |
| 01/07/2003 | US6503911 Administering a sustained release pharmaceutical dosage form including ranolazine for therapy of cardiovascular disease selected from arrhythmias, variant and exercise-induced angina, and myocardial infarction |
| 01/07/2003 | US6503908 Pharmaceutically active compounds |
| 01/07/2003 | US6503907 Indole and dihydroindole derivatives |
| 01/07/2003 | US6503905 3,3-biarylpiperidine and 2,2-biarylmorpholine derivatives |
| 01/07/2003 | US6503713 Methods for identifying RNA binding compounds |
| 01/07/2003 | US6502789 Flexible kite |
| 01/07/2003 | CA2228524C Quinazolinone-containing pharmaceutical compositions for prevention of neovascularization and for treating human malignancies |
| 01/07/2003 | CA2075590C Hydantoin derivatives |
| 01/06/2003 | CA2392187A1 Combination preparation for the therapy of immunological diseases |
| 01/05/2003 | CA2390181A1 Sulfonyl aryl triazoles as anti-inflammatory/analgesic agents |
| 01/03/2003 | WO2003000896A2 POLYNUCLEOTIDES AND POLYPEPTIDES OF THE IFNα-5 GENE |
| 01/03/2003 | WO2003000886A1 Novel g protein-coupled receptor protein and dna thereof |
| 01/03/2003 | WO2003000864A2 Nucleic acid-associated proteins |
| 01/03/2003 | WO2003000859A2 G-protein coupled receptors |
| 01/03/2003 | WO2003000846A2 A novel g protein-coupled receptor, gave 3 |
| 01/03/2003 | WO2003000844A2 Protein modification and maintenance molecules |
| 01/03/2003 | WO2003000776A1 Biodegradable polyphosphoramidates for controlled release of bioactive substances |
| 01/03/2003 | WO2003000736A1 Humanized antibodies derived from dd-3b6/22, specific for the d-dimer fragment of fibrin |
| 01/03/2003 | WO2003000699A1 Substituted 1-oxa-2,8-diaza-spiro[4,5]dec-2-ene derivatives as medicaments for the treatment of pain |
| 01/03/2003 | WO2003000697A1 Furoisoquinoline derivative, process for producing the same, and use |
| 01/03/2003 | WO2003000695A1 Pyrrolopyrimidines as protein kinase inhibitors |
| 01/03/2003 | WO2003000694A1 6-phenyldihydropyrrolopyrimidinedione derivatives |
| 01/03/2003 | WO2003000691A1 Carboline derivatives as pdev inhibitors |
| 01/03/2003 | WO2003000688A1 Azaindoles |
| 01/03/2003 | WO2003000687A1 Tyrosine kinase inhibitors |
| 01/03/2003 | WO2003000684A1 Substituted naphthyl indole derivatives as inhibitors of plasminogen activator inhibitor type-1 (pai-1) |
| 01/03/2003 | WO2003000680A1 Diamine derivatives |
| 01/03/2003 | WO2003000678A1 Cyanoanthranilamide derivatives and the use thereof as medicaments |
| 01/03/2003 | WO2003000675A1 Substituted benzopyran derivatives against arrhythmia |
| 01/03/2003 | WO2003000671A1 Naphthyl benzofuran derivatives as inhibitors of plasminogen activator inhibitor-1 (pai-1) |
| 01/03/2003 | WO2003000668A1 Oxa(thia)zolidine compounds, process for preparation thereof and anti-inflammatory agents |
| 01/03/2003 | WO2003000666A1 5-ht receptor ligands and uses thereof |
| 01/03/2003 | WO2003000663A1 5-ht receptor ligands and uses thereof |
| 01/03/2003 | WO2003000657A1 Diamine derivatives |
| 01/03/2003 | WO2003000653A1 Substituted n-acyl aniline derivatives, production and use thereof as medicaments |
| 01/03/2003 | WO2003000649A1 6-(aryl-amido or aryl-amidomethyl)-naphthalen-2-yloxy-acidic derivatives as inhibitors of plasminogen activator inhibitor type-1 (pai-1) |
| 01/03/2003 | WO2003000634A1 Vitamin d receptor antagonists and related compositions and methods of use |
| 01/03/2003 | WO2003000323A1 Safety shield system for prefilled syringes |
| 01/03/2003 | WO2003000322A1 Safety shield system for prefilled syringes |
| 01/03/2003 | WO2003000293A1 Pharmaceutical formulation |
| 01/03/2003 | WO2003000273A1 Modulating serum amyloid a interaction with tanis and agents useful for same |
| 01/03/2003 | WO2003000261A1 Use of bicyclo compounds for treating alzheimer's disease |
| 01/03/2003 | WO2003000256A1 Substituted oxazolidinones for combinational therapy |
| 01/03/2003 | WO2003000252A1 5-halo-tryptamine derivatives used as ligands of the 5-ht6 and/or 5-ht7 serotonin receptors |
| 01/03/2003 | WO2003000240A2 Stable powder inhalation dosage formulation |
| 01/03/2003 | WO2003000239A1 Stable pharmaceutical compositions containing pravastatin |